Effects of Atx and Oros-mph on Executive Functions
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The aim of this study was to evaluate and compare the effects of Atomoxetine(ATX) and osmotic
release oral system-methylphenidate (OROS-MPH) therapies on executive functions, activities,
treatment response time and adverse effects based on discernible clinical effects in children
with combined type attention deficit-hyperactivity disorder (ADHD).